“The test can be likened to a ‘cancer smoke detector’,” said Professor Gareth Jenkins, who led the research, adding that the disease might be detectable in 80 per cent of cancer patients.
“We are looking for the ‘scent’ of the cancer, which is present in the circulating blood,” he said. Read more . . .